Evaluating the efficacy of secondary transurethral resection of the bladder for high-grade Ta tumors

被引:2
作者
Lee, Kyeongchae [1 ]
Jeong, Seung-Hwan [1 ]
Yoo, Sang-Hyun [1 ]
Ku, Ja Hyeon [1 ]
机构
[1] Seoul Natl Univ Hosp, Dept Urol, 101 Daehak Ro, Seoul 03080, South Korea
关键词
Recurrence; Survival rate; Urinary bladder neoplasms; UROTHELIAL CARCINOMA; EAU GUIDELINES; CANCER; PROGRESSION; STAGE; RISK; CLASSIFICATION; RECURRENCE; MORTALITY; SURVIVAL;
D O I
10.4111/icu.20210314
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The need for secondary transurethral resection of the bladder (re-TURB) in patients with high-grade Ta tumors has not been assessed. This study aimed to compare the outcomes of patients with high-grade Ta tumors who did and did not undergo re-TURB. Materials and Methods: This study used data from the Seoul National University Prospectively Enrolled Registry for Urothelial Cancer-Transurethral Bladder Tumor Resection (SUPER-UC-TURB). Patients with high-grade Ta tumors who underwent TURB be-tween March 2016 and December 2019 were included. Following the initial TURB, if the pathology results showed a tumor grade higher than high-grade Ta, re-TURB was performed according to the surgeon's recommendation. The recurrence-free survival rate was assessed by Kaplan-Meier analysis and Cox regression analysis between patients who did and did not undergo re-TURB. Results: In total, 187 patients with high-grade Ta who underwent initial TURB were included, of whom 115 underwent re-TURB and 72 did not. Patients in the re-TURB group had a significantly higher 2-year recurrence-free survival rate than did those in the no re-TURB group (81.3% vs. 60.1%; p=0.005). Whether patients underwent re-TURB was a significant predictor of the risk of blad-der cancer recurrence in both the univariate (HR, 0.52; 95% CI, 0.27-0.98; p=0.044) and multivariate (HR, 0.41; 95% CI, 0.19-0.97; p=0.041) analysis. Conclusions: The risk for bladder cancer recurrence was increased, and the 2-year recurrence-free survival was significantly de-creased, in patients with high-grade Ta tumors who did not undergo re-TURB. Thus, re-TURB is beneficial in patients with high-grade Ta bladder cancer.
引用
收藏
页码:14 / 20
页数:7
相关论文
共 20 条
[1]   Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends [J].
Antoni, Sebastien ;
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Znaor, Ariana ;
Jemal, Ahmedin ;
Bray, Freddie .
EUROPEAN UROLOGY, 2017, 71 (01) :96-108
[2]  
Ayati M, 2019, UROL J, V16, P152, DOI 10.22037/uj.v0i0.4670
[3]   EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016 [J].
Babjuk, Marko ;
Boehle, Andreas ;
Burger, Maximilian ;
Capoun, Otakar ;
Cohen, Daniel ;
Comperat, Eva M. ;
Hernandez, Virginia ;
Kaasinen, Eero ;
Palou, Joan ;
Roupret, Morgan ;
van Rhijn, Bas W. G. ;
Shariat, Shahrokh F. ;
Soukup, Viktor ;
Sylvester, Richard J. ;
Zigeuner, Richard .
EUROPEAN UROLOGY, 2017, 71 (03) :447-461
[4]   Challenging the EAU Guidelines Regarding Early Repeat Transurethral Resection [J].
Brausi, Maurizio A. .
EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (03) :E5-E7
[5]   Epidemiology and Risk Factors of Urothelial Bladder Cancer [J].
Burger, Maximilian ;
Catto, James W. F. ;
Dalbagni, Guido ;
Grossman, H. Barton ;
Herr, Harry ;
Karakiewicz, Pierre ;
Kassouf, Wassim ;
Kiemeney, Lambertus A. ;
La Vecchia, Carlo ;
Shariat, Shahrokh ;
Lotan, Yair .
EUROPEAN UROLOGY, 2013, 63 (02) :234-241
[6]   Predicting cancer progression in patients with stage T1 bladder carcinoma [J].
Cheng, L ;
Neumann, RM ;
Weaver, AL ;
Spotts, BE ;
Bostwick, DG .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) :3182-3187
[7]   Surveillance of Urothelial Carcinoma Stage and Grade Migration, 1993-2005 and Survival Trends, 1993-2000 [J].
David, Kevin A. ;
Mallin, Katherine ;
Milowsky, Matthew I. ;
Ritchey, Jamie ;
Carroll, Peter R. ;
Nanus, David M. .
CANCER, 2009, 115 (07) :1435-1447
[8]   Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy [J].
Gupta, Amit ;
Lotan, Yair ;
Bastian, Patrick J. ;
Palapattu, Ganesh S. ;
Karakiewicz, Pierre I. ;
Raj, Ganesh V. ;
Schoenberg, Mark P. ;
Lerner, Seth P. ;
Sagalowsky, Arthur I. ;
Shariat, Shahrokh F. .
UROLOGY, 2008, 71 (02) :302-307
[9]   The value of a second transurethral resection in evaluating patients with bladder tumors [J].
Herr, HW .
JOURNAL OF UROLOGY, 1999, 162 (01) :74-76
[10]   Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome [J].
Herr, HW .
JOURNAL OF UROLOGY, 2000, 163 (01) :60-61